Liver-X-receptor agonism enhances T cell priming and activation to promote anti-tumor immunity
{{output}}
Many cancer patients do not benefit from current immunotherapies. This lack of efficacy may be, in part, due to insufficient priming and activation of T cells. Here, we show that activation of liver-X-receptors (LXRs) promotes adaptive anti-tumor immunity by e... ...